Could a pill replace hospital infusions for leukemia patients?
Disease control
Not yet recruiting
This study is testing if a new pill form of arsenic trioxide works as well as the standard intravenous (IV) infusion for treating a specific type of leukemia called acute promyelocytic leukemia (APL). The goal is to see if the pill is absorbed similarly, is safe, and controls the…
Phase: PHASE3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC